Patents
Patents for C07K 19 - Hybrid peptides (29,428)
03/1999
03/31/1999EP0904402A1 Interaction trap systems for detecting protein interactions
03/31/1999EP0904368A1 Al-2 neurotrophic factor
03/31/1999EP0904366A1 Apo-2li and apo-3 apoptosis polypeptides
03/31/1999EP0904288A2 Pathogenic escherichia coli associated protein
03/30/1999US5889168 Fusion glycoprotein from HCMV and HSV
03/30/1999US5889157 Humanized B3 antibody fragments, fusion proteins, and uses thereof
03/30/1999US5888833 Antigens recognized by antibodies to rheumatoid arthritis, their preparation and their applications
03/30/1999US5888732 Recombinational cloning using engineered recombination sites
03/30/1999US5888517 Protein D-an IgD-binding protein of Haemophilus influenzae
03/30/1999US5888508 Monoclonal antibodies against leukocyte adhesion receptor β-chain methods of producing these antibodies and use therefore
03/30/1999CA1340472C Universal t-cell epitope derived from p. faciparum circumsporosoite protein
03/25/1999WO1999014330A1 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
03/25/1999WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999WO1999014326A1 Mage-3 peptides presented by hla class ii molecules
03/25/1999WO1999000494A3 Cell activation process and reagents therefor
03/25/1999CA2382506A1 Novel polypeptides and nucleic acids encoding pro293 which are useful for treating disorders of the pancreas
03/25/1999CA2382495A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2382409A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303225A1 Dna30942 polypeptide, a tnfr homolog
03/24/1999EP0903408A2 Tat-derived transport polypeptide
03/23/1999US5885793 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
03/18/1999WO1999013095A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999WO1999013090A1 Regulation of protein secretion
03/18/1999CA2303396A1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/17/1999EP0902086A1 Tuberculosis vaccine
03/17/1999EP0614465B1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG
03/17/1999EP0563296B1 Optimization of binding proteins
03/17/1999CN1211255A Ob receptor and method of diagnosing and treating weight
03/16/1999US5883230 Multidomain hematopoiesis stimulators
03/16/1999US5883225 Polypeptides and sequence
03/16/1999US5882860 Hybridization of nucleic acid derived from cell with polynucleotide; genetic engineering; suppressing gene expression
03/16/1999CA1340431C Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
03/11/1999WO1999011809A1 Conjugates that contain the homeodomain of antennapedia
03/11/1999WO1999011774A1 Polypeptides comprising a coiled-coil and an addition site
03/11/1999WO1999011661A1 Biomolecules comprising an elastomeric peptide
03/11/1999WO1999011282A1 Compositions and methods for contraception in or sterilization of mammals
03/11/1999WO1998050547A3 Human toll-like receptor proteins, related reagents and methods
03/11/1999CA2302394A1 Polypeptides comprising a coiled-coil and an addition site
03/11/1999CA2301981A1 Biomolecules comprising an elastomeric peptide
03/11/1999CA2301157A1 Conjugates that contain the homeodomain of antennapedia
03/10/1999EP0900272A2 Tumor necrosis factor alpha convertase
03/10/1999CN1210558A Recombinant phages
03/09/1999US5880259 Peptide useful as a ligand
03/09/1999US5879904 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
03/09/1999US5879687 Enhancing or eliciting cellular and/or humoral immune response, for treating tumors
03/09/1999US5879679 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
03/09/1999CA2038279C Cd25 binding molecules
03/04/1999WO1999010510A2 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
03/04/1999WO1999010506A1 Mosaic protein and restriction endonuclease assisted ligation method for making the same
03/04/1999WO1999010496A1 Tuberculosis vaccine
03/04/1999WO1999010495A1 Cytokine designated lerk-6
03/04/1999WO1999010494A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
03/04/1999WO1999010484A1 Rtd receptor
03/04/1999WO1999010376A1 Inducible regulatory system and use thereof
03/04/1999WO1999010375A2 Vaccine against hpv
03/04/1999CA2301879A1 Tuberculosis vaccine
03/04/1999CA2301847A1 Rtd receptor
03/04/1999CA2301776A1 Mosaic protein and restriction endonuclease assisted ligation method for making the same
03/04/1999CA2301497A1 Cytokine designated lerk-6
03/04/1999CA2300376A1 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
03/03/1999EP0595798B1 Bispecific heteroantibodies with dual effector functions
03/03/1999EP0565590B1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE)
03/03/1999CN1209840A Noval CREBa phenogen
03/03/1999CN1209833A Process for removing or bleaching soilng or stains from cellulosic fabric
03/03/1999CN1209455A DNA of encoding plasminogen excited protein
03/02/1999US5877305 DNA encoding biosynthetic binding protein for cancer marker
03/02/1999US5877302 Compacted nucleic acids and their delivery to cells
03/02/1999US5877293 CDR grafted anti-CEA antibodies and their production
03/02/1999US5877291 Multivalent single chain antibodies
03/02/1999US5877290 Humanized antibody fragment that binds a polypeptide sequence encoded by cdna of an anti-hypercalcemic hormone; treatment of electrolyte disorders, kidney failure, bone and heart disorders, osteoporosis, paget's disease
03/02/1999US5877279 Materials for the production of nanometer structures and use thereof
03/02/1999US5877016 Human trk receptors and neurotrophic factor inhibitors
03/02/1999US5876969 Fusion polypeptide of therapeutic polypeptides attatched to c-and n-terminals of human serum albumin; for high plasma stability, minimization of dosage, side effect reduction
03/02/1999US5876968 Mixture of disulfide bonded dimer of al-milano, lipid lowering agent, and carrier; drug for treatment of athlerosclerosis and cardiovascular disease; prodrug for monomer; prevention of thrombosis
03/02/1999US5876965 Nucleic acid encoding ARF-19, a novel regulator of the mammalian cell cycle
03/02/1999US5876722 Hybrid protein
03/02/1999US5876718 Using antibodies which bind to protein
02/1999
02/25/1999WO1999009189A1 Gene coding for androctonine, vector containing same and transformed disease-resistant plants obtained
02/25/1999WO1999009186A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999WO1999009179A2 Antigen constructs useful in the detection and differentiation of antibodies to hiv
02/25/1999WO1999009166A2 Prostate tumor polynucleotide and antigen compositions
02/25/1999WO1999009063A1 Interleukin-18 binding proteins, their preparation and use
02/25/1999CA2301978A1 Gene coding for androctonine, vector containing same and transformed disease-resistant plants obtained
02/25/1999CA2301374A1 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999CA2300364A1 Prostate tumor polynucleotide and antigen compositions
02/25/1999CA2298855A1 Interleukin-18 binding proteins, their preparation and use
02/23/1999US5874541 Immunoglobulin or fragment is modified such that heavy chain variable region have been replaced by specific sequence or amino acids of a heavy chain immunogloblin comprising two heavy polypeptide chain consisting of antigen binding site
02/23/1999US5874533 HIV-2 envelope polypeptides
02/23/1999US5874528 Binding peptides which interact with ligand growth factors of the epidermal growth factor receptor and erbB-2 receptor
02/23/1999US5874399 Progenitor B cell stimulating factor
02/23/1999US5874304 Humanized green fluorescent protein genes and methods
02/23/1999US5874287 Mutagenized DNA molecules encoding modified subunit a of Cholera-toxin
02/23/1999US5874275 Nucleic acid sequences, vectors and cells
02/23/1999US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences
02/23/1999US5874267 Expression of surface layer proteins
02/23/1999US5874083 Proteins and complexes for immune response
02/18/1999WO1999007860A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
02/18/1999WO1999007414A1 Vectors derived from antibodies for transferring substances into cells